Filter
1894
Filtered Results: 1894
Text search:
health
recipient
Featured
Recommendations
161
New Publications
478
Language
Document type
No document type
1015
Guidelines
302
Studies & Reports
299
Manuals
120
Strategic & Response Plan
61
Fact sheets
41
Training Material
28
Situation Updates
12
Resource Platforms
7
Infographics
6
Online Courses
2
Brochures
1
Countries / Regions
Global
106
India
55
Kenya
40
South Africa
40
Latin America and the Carribbean
35
Western and Central Europe
35
Nepal
33
Myanmar / Burma
30
Mozambique
28
Uganda
27
Liberia
26
Nigeria
26
Ethiopia
26
Brazil
26
Tanzania
24
Malawi
24
Sierra Leone
23
Ukraine
22
Africa
22
Zambia
21
Bangladesh
20
Syria
18
Rwanda
18
Congo, Democratic Republic of
17
Philippines
17
Eastern Europe
16
Colombia
15
Senegal
14
Ghana
14
Paraguay
14
Namibia
12
Guinea
11
Asia
11
Venezuela
11
Burkina Faso
10
Zimbabwe
10
Haiti
10
Cambodia
10
Lesotho
10
Indonesia
9
Angola
9
Pakistan
8
Germany
8
Peru
8
West and Central Africa
8
South–East Asia Region
8
Mali
7
Cameroon
7
Bolivia
7
Côte d’Ivoire / Ivory Coast
6
Benin
6
Botswana
6
Yemen
6
East and Southern Africa
6
Middle East and North Africa
6
South Sudan
5
Thailand
5
China
5
Argentina
5
Western Pacific Region
5
Russia
5
Moldova
5
Guinea-Bissau
4
Central African Republic
4
Eswatini/ Swaziland
4
Ecuador
4
Sri Lanka
4
Albania
4
Tajikistan
4
Vietnam
4
Niger
3
Jordan
3
Lebanon
3
Chad
3
Sudan
3
North Macedonia
3
Chile
3
Eastern Europe and Central Asia
3
Bhutan
3
Laos
3
Spain
3
Togo
2
Afghanistan
2
Madagascar
2
Palestine
2
Canada
2
Georgia
2
USA
1
Somalia
1
Iraq
1
Malaysia
1
Singapore
1
Dominican Republic
1
Switzerland
1
Burundi
1
El Salvador
1
Libya
1
Guatemala
1
Fiji
1
Armenia
1
Southern Africa
1
Lithuania
1
Kyrgyzstan
1
Kazakhstan
1
Japan
1
Mauritius
1
United Kingdom
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
610
Key Resources
129
Clinical Guidelines
127
Public Health
92
Women & Child Health
75
Pharmacy & Technologies
38
Capacity Building
30
Annual Report MEDBOX
1
Toolboxes
COVID-19
260
HIV
134
Disability
96
Mental Health
91
Health Financing Toolbox
91
TB
90
Rapid Response
74
Pharmacy
55
Caregiver
50
Planetary Health
49
Ebola
45
NTDs
45
Conflict
40
Refugee
40
AMR
33
Natural Hazards
31
Global Health Education
31
Zika
21
Cholera
14
Social Ethics
13
NCDs
11
Polio
10
Specific Hazards
4
Typhoon
2
Health Financing
2
COVID-19 has heavily emphasized how contact tracing is crucial for managing outbreaks, and as part of the strategy for adjusting, and eventually lifting, lockdowns and other stringent public health and social measures. As the pandemic develops furth...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inpu...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Vacinação contra a COVID-19: orientações relativas ao abastecimento e logística, 12 Fevereiro 2021
recommended
12 February 2021
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
More than 700 000 people lose their life to suicide every year. The world is not on track to reach the 2030 suicide reduction targets. WHO advocates for countries to take action to prevent suicide, ideally through a comprehensive national suicide prevention strategy. Governments and communities can ...
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
recommended
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases (NCDs), focusing on cardiovascular diseases and diabetes, especially for low- and middle-income countries to support universal ... coverage actions.
Pessoas privadas de liberdade, por exemplo, detentos em presídios e outros locais de detenção, podem estar mais vulneráveis a doença do coronavírus (COVID-19) quando comparadas à população em geral, devido às condições de confinamento em que vivem com outras pessoas por períodos prolong...
The primary audience for this guidance is persons
working directly in vector-borne disease prevention
and control, including programme managers,
researchers and field workers. A brief technical
background is provided for the benefit of persons
without expertise in vector-borne diseases; readers...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and pe...
